Advertisement
Advertisement

INM

INM logo

InMed Pharmaceuticals Inc. Common Shares

1.55
USD
Sponsored
+0.05
+3.33%
Jun 24, 16:00 UTC -4
Closed
exchange

After-Market

1.55

0.00
-0.06%

INM Earnings Reports

Positive Surprise Ratio

INM beat 2 of 7 last estimates.

29%

Next Report

Date of Next Report
--
Estimate for Q-- -- (Revenue/ EPS)
--
/
--
Implied change from Q3 26 (Revenue/ EPS)
--
/
--
Implied change from Q-- -- (Revenue/ EPS)
--
/
--

InMed Pharmaceuticals Inc. Common Shares earnings per share and revenue

On May 11, 2026, INM reported earnings of -- USD per share (EPS) for Q3 26, -- the estimate of -- USD, resulting in a --% surprise. Revenue reached --, compared to an expected --, with a --% difference.
Looking ahead to -- --, -- analysts forecast an EPS of -- USD, with revenue projected to reach -- USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.
FAQ
For Q3 2026, InMed Pharmaceuticals Inc. Common Shares reported EPS of --, missing estimates by --, and revenue of --, -- -- expectations.
The stock price moved -- --, changed from -- before the earnings release to -- the day after.
The next earning report is scheduled for --.
Based on -- analysts, InMed Pharmaceuticals Inc. Common Shares is expected to report EPS of -- and revenue of -- for Q-- --.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement